询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Diisopropyl succinate | CAS:924-88-9
Diisopropyl succinate
  • 名称:丁二酸二异丙酯 | Diisopropyl succinate
  • CAS号:924-88-9
  • 别名:Succinic acid diisopropyl ester
  • 分子式:C10H18O4
  • 分子量:202.25
  • EINESC号:213-110-0

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
TCI 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.Georg Hopfinger et al.Cancer, 119(12), 2258-2267 (2013-03-21) Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.Izabela Sadowska-Bartosz et al.Journal of neuroimmunology, 266(1-2), 67-74 (2013-12-03) Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.Valeria Feinshtein et al.American journal of obstetrics and gynecology, 209(6), 573-573 (2013-08-13) Cladribine in the treatment of acute myeloid leukemia.Tadeusz Robak et al.Leukemia research, 38(4), 425-427 (2014-02-04) Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.Vugar Yagublu et al.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 13(1), 79-87 (2013-02-12) Outcome of poor response paediatric AML using early SCT.Neval E Wareham et al.European journal of haematology, 90(3), 187-194 (2012-12-12) Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh]isoquinolinone derivatives.Manochehr Shahabi et al.Bioorganic & medicinal chemistry letters, 23(6), 1846-1852 (2013-02-12) Estrogen receptor α induction by mitoxantrone increases Abcg2 expression in placental trophoblast cells.Kenji Oda et al.Journal of pharmaceutical sciences, 102(9), 3364-3372 (2013-04-18) Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.Yu-Gang Zhuang et al.Die Pharmazie, 67(11), 925-929 (2012-12-06) The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.Markus Axelsson et al.Journal of neuroimmunology, 264(1-2), 100-105 (2013-10-16) Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics.Adi Tzur-Balter et al.Acta biomaterialia, 9(9), 8346-8353 (2013-06-19) Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Robert S Nickel et al.Pediatric blood & cancer, 61(5), 810-814 (2013-12-21) Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.Krupa J Patel et al.Cancer chemotherapy and pharmacology, 72(1), 127-138 (2013-05-18) Role of immunosuppressive therapy for the treatment of multiple sclerosis.James M Stankiewicz et al.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 10(1), 77-88 (2012-12-29) A case report of acute myeloid leukemia after liver transplantation.Mingjuan Liu et al.Acta haematologica, 129(4), 225-228 (2013-01-09) Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatments.Robert J Amato et al.Cancer investigation, 31(3), 177-182 (2013-02-14) Novel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatments.Thiruganesh Ramasamy et al.Journal of biomedical nanotechnology, 10(7), 1304-1312 (2014-05-09) Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.Dario Ferrero et al.Annals of hematology, 93(8), 1391-1400 (2014-04-08) Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy.Susan Halabi et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(31), 3944-3950 (2013-10-09) Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure.Michael V Jaglal et al.Leukemia research, 38(4), 443-446 (2014-01-21) Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.Samir H Barghout et al.Leukemia, 33(1), 37-51 (2018-06-10) Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.Adi Tzur-Balter et al.Acta biomaterialia, 9(4), 6208-6217 (2013-01-01) Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes.Qiang Huang et al.BMC microbiology, 19(1), 274-274 (2019-12-10) Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.Zhiyong Yu et al.Internal medicine (Tokyo, Japan), 52(6), 689-693 (2013-03-19) AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.Hui Zhang et al.Cancer letters, 350(1-2), 61-68 (2014-04-22) Mechanism-independent optimization of combinatorial nanodiamond and unmodified drug delivery using a phenotypically driven platform technology.Hann Wang et al.ACS nano, 9(3), 3332-3344 (2015-02-18) On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs.Chyuan-Chuan Wu et al.Nucleic acids research, 41(22), 10630-10640 (2013-09-17) A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.FitzGerald J PLoS ONE, 9, e98891-e98891 (2014) Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A.A D Garg et al.Cell death & disease, 4, e826-e826 (2013-10-05) Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.Yuting Ma et al.The Journal of experimental medicine, 208(3), 491-503 (2011-03-09) Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.Zdzisław Maciejek et al.Neurologia i neurochirurgia polska, 47(2), 145-151 (2013-05-08) BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.J M Day et al.British journal of cancer, 100(3), 476-486 (2009-01-22) High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission.Mona Hassanein et al.Leukemia research, 37(5), 556-560 (2013-01-30) Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.Sobiya Zafar et al.International journal of pharmaceutics, 477(1-2), 454-468 (2014-12-03) High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.Bushan Xie et al.Biochemical and biophysical research communications, 521(1), 232-237 (2019-10-28) Molecular mechanism of T-cell protein tyrosine phosphatase (TCPTP) activation by mitoxantrone.Mikko Ylilauri et al.Biochimica et biophysica acta, 1834(10), 1988-1997 (2013-07-17) Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.Shweta Agarwal et al.Journal of photochemistry and photobiology. B, Biology, 120, 177-182 (2012-12-26) Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.Jurjen M Ruben et al.Cancer immunology, immunotherapy : CII, 63(4), 335-345 (2014-01-05) R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.Massimo Federico et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1506-1513 (2013-03-27) Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.Jorge E Cortes et al.Cancer, 121(2), 234-242 (2014-09-17) Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).Sergio Amadori et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(35), 4424-4430 (2013-10-16) Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma.Véronique Sicotte et al.Journal of the American Veterinary Medical Association, 241(12), 1639-1644 (2012-12-12) A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.Michod D Oncogene, 23, 8971-8971 (2004) Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress.Juliette Humeau et al.EMBO molecular medicine, 12(5), e11622-e11622 (2020-04-24) Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells.Abraham Lin et al.Advanced science (Weinheim, Baden-Wurttemberg, Germany), 6(6), 1802062-1802062 (2019-04-03) Unblending of Transcriptional Condensates in Human Repeat Expansion Disease.Shaon Basu et al.Cell, 181(5), 1062-1079 (2020-05-11) Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.Janet M Pavese et al.Cancer letters, 352(2), 179-186 (2014-07-13) Chromium(VI) but not chromium(III) species decrease mitoxantrone affinity to DNA.Anna M Nowicka et al.The journal of physical chemistry. B, 117(4), 1021-1030 (2013-01-09) Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.Jae-Sook Ahn et al.Acta haematologica, 133(1), 91-97 (2014-08-30) Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.Florence Joly et al.BJU international, 115(1), 65-73 (2013-11-05) Release of an ~55kDa fragment containing the actin-binding domain of β-spectrin by caspase-8 during FND-induced apoptosis depends on the presence of protein 4.1.Monika Toporkiewicz et al.Archives of biochemistry and biophysics, 535(2), 205-213 (2013-04-13) IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.Sanjoy Samanta et al.The Journal of biological chemistry, 288(18), 12569-12573 (2013-03-30) Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure.Korbelik M International Immunopharmacology, 20, 359-359 (2014) Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines.Korbelik M Frontiers in Oncology, 5, 15-15 (2015) Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.Sachit A Patel et al.Journal of pediatric hematology/oncology, 36(6), 491-494 (2013-12-11) Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.Denise P Muñoz et al.JCI insight, 5 (2019-06-12) Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.Jae-Ho Yoon et al.American journal of hematology, 88(12), 1074-1081 (2013-08-29) Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.M Adamczyk-Sowa et al.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 63(6), 683-690 (2013-02-08) Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.Pau Abrisqueta et al.Blood, 122(24), 3951-3959 (2013-10-15) Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.Enrico Derenzini et al.British journal of haematology, 166(4), 625-628 (2014-04-23) Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.Pier Luigi Zinzani et al.American journal of hematology, 88(11), E273-E276 (2013-07-12) A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.Xiaobo Wan et al.Journal of medicinal chemistry, 56(6), 2619-2629 (2013-02-28) Mitoxantrone-related acute leukemia in MS: an open or closed book?Andrew Chan et al.Neurology, 80(16), 1529-1533 (2013-04-17) Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.Susan Halabi et al.Journal of the National Cancer Institute, 105(22), 1729-1737 (2013-10-19) MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).Meng-Tao Ma et al.Cancer letters, 339(1), 107-115 (2013-07-25) In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles.Kwon-Jai Lee et al.Journal of biomedical nanotechnology, 9(6), 1071-1075 (2013-07-19) Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI.James A Taylor et al.PloS one, 8(2), e58010-e58010 (2013-03-08) Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia.Michaela Liedtke et al.Leukemia research, 38(12), 1441-1445 (2014-12-03) Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy.Nathaniel Huebsch et al.Proceedings of the National Academy of Sciences of the United States of America, 111(27), 9762-9767 (2014-06-26) Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure.Mladen Korbelik et al.International immunopharmacology, 20(2), 359-365 (2014-04-10) A template model for studying anticancer drug efflux transporter inhibitors in vitro.Alexandre Sostelly et al.Fundamental & clinical pharmacology, 27(5), 544-556 (2012-08-14) Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.Fang-Fang Huang et al.Cancer letters, 336(1), 96-105 (2013-04-23)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交